Conclusion
We conclude that, although major complications are more common in obese patients, the increase in BMI does not reveal a significant negative effect on OS, CSS, RFS and MFS.
Across the spe ctrum of obese patients undergoing RARC with intracorporeal diversion, quality of surgery, postoperative data, pathological outcomes, complications and readmission rates were similar. Early oncological outcomes were also similar amongst patients in all four BMI categories. We conclude that, given an experienced robot-assisted surgery team, RARC with intracorporeal diversion is an effective option for overweight, obese and morbidly obese patients with bladder cancer who are considering RC. Across the spectrum of obese patients undergoing RARC with intracorporeal diversion, quality of surgery, postoperative data, pathological outcomes, complicationsand readmission rates were similar. Early oncological outcomes were also similar amongst patients in all four BMI categories. We conclude that, given an experienced robot-assisted surgery team, RARC with intracorporeal diversion is an effective option for overweight, obese and morbidly obese patients with bladder cancer who are considering RC.